EPIGENT is a groundbreaking data-driven solution aimed at defeating infectious diseases particularly meningitis and COVID-19 through smart vaccination strategies. Focused on high-risk regions like the African meningitis belt, EPIGENT combines AI-driven simulations, agent-based modeling, and predictive analytics to inform public health decisions and optimize vaccine campaigns. By shifting away from reactive outbreak responses toward proactive modeling, EPIGENT helps save lives, prevent disabilities, and reduce the economic burden of disease. Through four core steps uploading regional data, running simulations, analyzing results, and exporting tailored policy briefs EPIGENT empowers governments and health organizations to allocate resources more efficiently and act early.

The EPIGENT platform’s capabilities are designed to model disease spread, test multiple vaccination strategies, and plan for eradication timelines, particularly where shifting serogroups complicate prevention efforts. With the potential to reduce meningitis cases by 50%, save over a million lives, and generate $500M in healthcare savings annually, EPIGENT serves 26 countries across sub-Saharan Africa. It fills a deadly gap in vaccine-preventable disease response by enabling real-time insights into high-risk populations and offering actionable solutions long before outbreaks occur.